Search Results - "Tugçe Nur Yigenoglu"
-
1
-
2
Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study
Published in Medicine (Baltimore) (15-10-2021)“…Certain genetic mutations could have a role in the etiology of acute myeloid leukemia (AML). Hereby, in this study, we primarily aimed to investigate the…”
Get full text
Journal Article -
3
Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations
Published in Medicine (Baltimore) (01-04-2020)“…Effects of mutations on AML (acute myeloid leukemia) patients have been an area of clinical interest. The aim of this study was to analyze pre-chemotherapy WBC…”
Get full text
Journal Article -
4
Is neutropenic fever an obstacle to effective stem cell harvesting?
Published in Asian journal of transfusion science (01-01-2024)“…Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A…”
Get full text
Journal Article -
5
Peripheral stem cell mobilization strategies in patients with autologous hematopoietic cell transplantation: A single center's experience
Published in Jurnal teknologi laboratorium (Online) (31-12-2020)“…This research is to investigate the parameters which may affect the mobilization of stem cells in patients receiving autologous hematopoietic peripheral blood…”
Get full text
Journal Article -
6
Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption
Published in Transfusion and apheresis science (01-08-2020)“…The activation of the innate and adaptive immune systems by SARS-CoV-2 causes the release of several inflammatory cytokines, including IL-6. The inflammatory…”
Get full text
Journal Article -
7
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Published in Journal of oncology pharmacy practice (01-10-2020)“…Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI)…”
Get full text
Journal Article -
8
Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease
Published in Journal of oncology pharmacy practice (01-06-2022)“…Introduction Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic cell transplantation (HCT). In the treatment of chronic…”
Get full text
Journal Article -
9
Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities
Published in Journal of oncology pharmacy practice (01-06-2022)“…Introduction The most common kind of leukemia in adults is chronic lymphocytic leukemia (CLL). CLL is treated with ibrutinib. During the course of ibrutinib…”
Get full text
Journal Article -
10
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
Published in Journal of chemotherapy (Florence) (03-04-2022)“…The prognosis is poor for relapsed or refractory (R/R) classical Hodgkin Lymphoma (cHL) patients. The brentuximab vedotin (Bv) and bendamustine (B) combination…”
Get full text
Journal Article -
11
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
Published in Internal and emergency medicine (01-01-2022)“…Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical…”
Get full text
Journal Article -
12
Old is bad? The effect of age on peripheral stem cell mobilization and transplantation outcomes
Published in Transfusion and apheresis science (01-02-2021)“…•Allogeneic stem cell transplantation is now being applied to elderly patients.•Elderly donors often have HLA matched elderly siblings.•Adequate stem cell…”
Get full text
Journal Article -
13
An effective treatment in Erdheim Chester disease: vemurafenib: a case report
Published in Journal of medical case reports (12-10-2023)“…Abstract Background Erdheim Chester disease (ECD) is a rare disease with multisystemic involvement in the group of non-langerhans cell histiocytosis. Although…”
Get full text
Journal Article -
14
Tyrosine kinase inhibitors and COVID-19
Published in Journal of oncology pharmacy practice (01-12-2020)Get full text
Journal Article -
15
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience
Published in Journal of oncology pharmacy practice (01-12-2020)“…The optimal choice of salvage therapy for patients with relapsed/refractory non-Hodgkin lymphoma or Hodgkin lymphoma remains controversial. In this study, we…”
Get full text
Journal Article -
16
Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients
Published in Iraqi Journal of Hematology (01-01-2022)“…BACKGROUND: Febrile neutropenia (FN) is a serious problem, especially in hematologic malignancies, and can cause high mortality rates and it occurs in 10%–20%…”
Get full text
Journal Article -
17
Face masks and polycythemia is the standard hemoglobin cutoff valid in the pandemic?
Published in Iraqi Journal of Hematology (01-07-2022)“…BACKGROUND: Polycythemia is a common reason for patients' admissions. With the introduction of COVID-19, face masks reached very common usage in the…”
Get full text
Journal Article -
18
Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?
Published in Curēus (Palo Alto, CA) (11-11-2021)“…In this study, we aim to analyze the effect of total body irradiation (TBI) on neutrophil and thrombocyte engraftment durations in acute leukemia (AL) patients…”
Get full text
Journal Article -
19
Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
Published in Transfusion and apheresis science (01-08-2016)“…Abstract Introduction Microbial contamination can be a marker for faulty process and is assumed to play an important role in the collection of hematopoietic…”
Get full text
Journal Article -
20
Is the Optimal Timing First Complete Remission for Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma?
Published in Namık Kemal tıp dergisi (01-08-2021)“…Aim: Outcome for most patients with peripheral T-cell lymphomas (PTCLs) is poor, with low response rates and short durations of remission. We aim to analyze…”
Get full text
Journal Article